Search
for
Sort by
Research 121–150 of 680
- Phosphatidylinositol‐specific phospholipase C2 functions in auxin‐modulated root development
- Loss of adipocyte phospholipase gene PLAAT3 causes lipodystrophy and insulin resistance due to inactivated arachidonic acid-mediated PPARγ signaling
- Regulation of microvascular permeability by vascular endothelial growth factors
- Knock-Down of Arabidopsis PLC5 Reduces Primary Root Growth and Secondary Root Formation While Overexpression Improves Drought Tolerance and Causes Stunted Root Hair Growth
- Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARα and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways
- The prevention of benign prostatic hyperplasia (bph)
- Synaptic‐like vesicles and candidate transduction channels in mechanosensory terminals
- A network pharmacology-based approach to explore mechanism of action of medicinal herbs for alopecia treatment
- Colourless side of the <i>nude</i> mutation: Foxn1 and hair pigmentation
- Epigenetic Effects of Finasteride on Dopaminergic Signaling Pathways: A potential contributor to Post-Finasteride Syndrome
- Resequencing Analyses Revealed Genetic Diversity and Selection Signatures during Rabbit Breeding and Improvement
- Image2.TIF
- DataSheet1.zip
- Image1.TIF
- Presentation1.PPTX
- Loss of epidermal PLCg1 induced sebaceous gland hyperplasia and sparse hair
- sPLA2-IIA Overexpression in Mice Epidermis Depletes Hair Follicle Stem Cells and Induces Differentiation Mediated Through Enhanced JNK/c-Jun Activation
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Haff disease associated with the ingestion of the freshwater fish Mylossoma duriventre (pacu-manteiga)
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Clinical Manifestations of Dermatomyositis
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Baricitinib: A Review in Severe Alopecia Areata
- Visual Improvement in a Child With Periorbital Plexiform Neurofibroma Treated With Selumetinib: Case Report and Literature Review
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study